# Oncolytics Biotech Inc: Form 8-K, filed Apr 6, 2026

- Company: [Oncolytics Biotech Inc](/companies/oncy.md) (CIK 1129928)
- Form: 8-K
- Filed: 2026-04-06
- Accepted by EDGAR: Apr 6, 2026, 16:12 ET
- Period: 2026-04-06
- Accession: 0001104659-26-039935
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1129928/000110465926039935/tm2610715d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1129928/000110465926039935/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1129928/000110465926039935/tm2610715d2_8k.htm

Filed Apr 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-039935. Last ingested by Listed: Nov 4, 2026, 09:43 ET. No prices; not investment advice.